Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 12, 2024 10:27 ET | Source: Transparency Market Research

Human Papillomavirus Vaccine Market is Poised to Reach USD 9.1 billion by 2031 | Transparency Market Research, Inc.

Wilmington, Delaware, United States, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global human papillomavirus vaccine market was projected to attain US$ 4 billion in...
December 12, 2023 02:00 ET | Source: Icosavax, Inc.

Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults

Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
October 31, 2023 08:00 ET | Source: Icosavax, Inc.

Icosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conference

SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
August 14, 2023 16:05 ET | Source: Icosavax, Inc.

Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update

- Positive topline interim Phase 1 results for bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults - - Positive twelve-month immunogenicity data and initial proof-of-concept...
June 06, 2022 09:10 ET | Source: Research Dive

Human Papillomavirus Vaccine Market Expected to Garner $9,283.6 Million and Grow at 12.0% CAGR in the 2020-2027 Timeframe [230-Pages] | Reveals by Research Dive

New York, USA, June 06, 2022 (GLOBE NEWSWIRE) -- Press Release: As per the newly published report by Research Dive, the global human papillomavirus vaccine market is anticipated to grow at a...
August 03, 2021 09:27 ET | Source: Research Dive

Global Human Papillomavirus Vaccine Market Estimated to Generate a Revenue of $9,283.6 Million By 2027, Growing at a CAGR of 12.0% from 2020-2027 – Informative Report [238 Pages] by Research Dive

New York, USA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global human papillomavirus vaccine market is expected to generate a revenue of $9,283.6...
February 10, 2021 09:15 ET | Source: Research Dive

Global Human Papillomavirus Vaccine Market Projected to Reach up to $9,283.6 Million and Rise at a CAGR of 12.0% from 2020 to 2027 – Exclusive Report [238 Pages] by Research Dive

New York, USA, Feb. 10, 2021 (GLOBE NEWSWIRE) -- According to a newly published report by Research Dive, the global human papillomavirus vaccine market is estimated to generate $9,283.6 million by...